- Oct 3, 2018
- 2,957
| TYPE | Research & Development |
| COUNTRY | South Korea |
| PROJECT | Influenza Virus Vaccine - ROKOHTA-H1N1 - Exploratory & Theory Phase |
| PROJECT COST | 200,000,000.00 |
| COMPLETION DATE | 01/04/2021 |
| PROJECT INFORMATION | Influenza was first discovered in 1933, and since then has in its aggregate count infected millions and killed close to 650,000 people. In Korea, it accounts for 1.2% of deaths and has garnered the position from the Ministry of Science to invest in a vaccine to be procured for the infection. Without a current vaccine, the Republic of Korea Infectious Disease Control, Korean Center for Disease Control and prevention Agency, and Hanmi Pharmaceutical, Chongkundang, Celltrion have all begun to work towards a vaccine that may work to prevent and reduce the risk of infection with influenza. This explorer research will seek to isolate the strand DNA and RNA, while also looking at the virus' mitosis and replication abilities. Upon which, the vaccination will seek to develop antibodies that suppress and minimize impact form the virus. Upon completion of this exploratory research and viable vaccine candidates, pre-clinical trials will begin on animals before being approved for human test trials. The Current phases shall primarily consist of lab research aimed at identifying and isolating the natural strands as well as attempt to synthetically recreate the virus utilizing its RNA and DNA strands in an effort to replicate it and find ways to reduce its effectiveness. The current primary theory is the utilization of a created disease to weaken it and inject it to allow the body to naturally develop antibodies. Given the risk, the virus will be monitored and approved in staged by the KCDC and KIDC alongside partner universities in Korea University and Seoul National University. Influenza is airborne and spread through liquids. It can be spread through the nose, throat, and lungs. Primarily through people coughing, sneezing or talking, resulting in droplets of human liquids with the virus to dissipate and spread through the air and potentially into the mouths or noses of people who are nearby. Primary prevention measures include masks, distance, and personal hygiene. |
| PRIVATE / ENCRYPTED | No |
